M Starnawski

1.1k total citations · 1 hit paper
5 papers, 862 citations indexed

About

M Starnawski is a scholar working on Molecular Biology, Surgery and Dermatology. According to data from OpenAlex, M Starnawski has authored 5 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Dermatology. Recurrent topics in M Starnawski's work include Hedgehog Signaling Pathway Studies (3 papers), Cancer and Skin Lesions (2 papers) and Organ Transplantation Techniques and Outcomes (1 paper). M Starnawski is often cited by papers focused on Hedgehog Signaling Pathway Studies (3 papers), Cancer and Skin Lesions (2 papers) and Organ Transplantation Techniques and Outcomes (1 paper). M Starnawski collaborates with scholars based in Austria, Switzerland and United States. M Starnawski's co-authors include Jian Wu, Bernd Langer, Manish A. Shah, Sook Ryun Park, Sun Young Rha, Eric Van Cutsem, Akira Sawaki, Yoon‐Koo Kang, Atsushi Ohtsu and Ho Yeong Lim and has published in prestigious journals such as Journal of Clinical Oncology, Annales de Dermatologie et de Vénéréologie and PubMed.

In The Last Decade

M Starnawski

4 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

2011 845 citations Atsushi Ohtsu, Manish A. Shah et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Starnawski Austria	3	660	466	271	268	195	5	862
Claire Saffery United Kingdom	7	628 1.0×	569 1.2×	331 1.2×	198 0.7×	108 0.6×	17	886
G. Kurteva United States	10	678 1.0×	686 1.5×	254 0.9×	199 0.7×	180 0.9×	26	1.0k
Jong Inn Lee South Korea	6	676 1.0×	236 0.5×	339 1.3×	285 1.1×	90 0.5×	12	851
Sin Ho Jung South Korea	7	851 1.3×	183 0.4×	424 1.6×	423 1.6×	133 0.7×	8	1.0k
Mitsutoshi Tatsumi Japan	9	394 0.6×	337 0.7×	228 0.8×	115 0.4×	270 1.4×	25	756
Fabiola Lorena Rojas Llimpe Italy	10	498 0.8×	500 1.1×	217 0.8×	135 0.5×	117 0.6×	32	791
Guanghai Dai China	13	354 0.5×	359 0.8×	183 0.7×	125 0.5×	168 0.9×	34	670
K Miwa Japan	18	426 0.6×	285 0.6×	276 1.0×	248 0.9×	178 0.9×	44	866
Takeo Kosaka Japan	15	420 0.6×	219 0.5×	322 1.2×	208 0.8×	95 0.5×	85	769
Kosei Miyashita Japan	3	1.3k 1.9×	689 1.5×	520 1.9×	590 2.2×	150 0.8×	6	1.5k

Countries citing papers authored by M Starnawski

Since Specialization

Citations

This map shows the geographic impact of M Starnawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Starnawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Starnawski more than expected).

Fields of papers citing papers by M Starnawski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Starnawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Starnawski. The network helps show where M Starnawski may publish in the future.

Co-authorship network of co-authors of M Starnawski

This figure shows the co-authorship network connecting the top 25 collaborators of M Starnawski. A scholar is included among the top collaborators of M Starnawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Starnawski. M Starnawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kunstfeld, Rainer, Axel Hauschild, David Zloty, et al.. (2014). MIKIE: A randomized, double-blind, regimen-controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas.. Journal of Clinical Oncology. 32(15_suppl). TPS9121–TPS9121. 4 indexed citations

2.

Grob, Jean‐Jacques, Rainer Kunstfeld, Brigitte Dréno, et al.. (2013). Vismodegib, a Hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study interim analysis in 300 patients.. Journal of Clinical Oncology. 31(15_suppl). 9036–9036. 11 indexed citations

3.

Grob, Jean‐Jacques, Rainer Kunstfeld, Thomas Jouary, et al.. (2013). Vismodegib (V), un inhibiteur de la voie Hedgehog (HPI), dans le carcinome basocellulaire avancé (CBCa) : analyse intermédiaire de l’étude STEVIE. Annales de Dermatologie et de Vénéréologie. 140(12). S394–S394.

4.

Ohtsu, Atsushi, Manish A. Shah, Eric Van Cutsem, et al.. (2011). Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. Journal of Clinical Oncology. 29(30). 3968–3976. 845 indexed citations breakdown →

5.

Emerich, Janusz, et al.. (1999). [Pregnancy and delivery after liver transplantation: case report].. PubMed. 70(12). 907–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact